Benjamin Greenbaum

Benjamin Greenbaum has worked in a variety of roles since 2001. Theirfirst job was as a Physics/Mathematics Tutor for Advantage Testing in 2001. Benjamin then worked as a Graduate Research Assistant in the Theoretical Division of Los Alamos National Laboratory from 2001-2008. In 2008, they became a Long-Term Member at the Institute for Advanced Study. From 2013-2019, they were an Associate Professor and Director of the Center for Computational Immunology at the Icahn School of Medicine at Mount Sinai. In 2019, they became Co-Founder of ROME Therapeutics. In 2020, they began working as an Associate Member at Memorial Sloan Kettering Cancer Center and in 2021 they were appointed Associate Professor at Joan & Sanford I. Weill Medical College of Cornell University.

Benjamin Greenbaum obtained a Bachelor of Arts (B.A.) degree from Columbia University in 1997, majoring in Physics, Philosophy, and Mathematics. Benjamin then continued their studies at Columbia University, receiving their PhD in Physics in 2006.